skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: subject: Female remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial
Material Type:
Article 		Add to My Research

Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial

European journal of medical research, 2021-02, Vol.26 (1), p.20-20, Article 20 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2047-783X ;ISSN: 0949-2321 ;EISSN: 2047-783X ;DOI: 10.1186/s40001-021-00490-1 ;PMID: 33573699

Full text available

Citations Cited by
2
Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study
Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study
Material Type:
Article 		Add to My Research

Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study

European journal of medical research, 2021-05, Vol.26 (1), p.41-41, Article 41 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2047-783X ;ISSN: 0949-2321 ;EISSN: 2047-783X ;DOI: 10.1186/s40001-021-00513-x ;PMID: 33957992

Full text available

Citations Cited by
3
Assessing the Efficacy of Second-Line Antiretroviral Treatment for HIV Patients Failing First-Line Antiretroviral Therapy in Iran: A Cohort Study
Assessing the Efficacy of Second-Line Antiretroviral Treatment for HIV Patients Failing First-Line Antiretroviral Therapy in Iran: A Cohort Study
Material Type:
Article 		Add to My Research

Assessing the Efficacy of Second-Line Antiretroviral Treatment for HIV Patients Failing First-Line Antiretroviral Therapy in Iran: A Cohort Study

Acta medica Iranica, 2017-04, Vol.55 (4), p.233-240 [Peer Reviewed Journal]

Copyright Tehran University of Medical Sciences 2017 ;ISSN: 0044-6025 ;EISSN: 1735-9694 ;PMID: 28532134

Full text available

Citations Cited by
4
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
Material Type:
Article 		Add to My Research

A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19

Antimicrobial agents and chemotherapy, 2020-08, Vol.64 (9) [Peer Reviewed Journal]

Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.01061-20 ;PMID: 32661006

Full text available

Citations Cited by
5
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
Material Type:
Article 		Add to My Research

Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial

Pharmacological reports, 2022-02, Vol.74 (1), p.229-240 [Peer Reviewed Journal]

The Author(s) under exclusive licence to Maj Institute of Pharmacology Polish Academy of Sciences 2021 ;2021. The Author(s) under exclusive licence to Maj Institute of Pharmacology Polish Academy of Sciences. ;ISSN: 1734-1140 ;EISSN: 2299-5684 ;DOI: 10.1007/s43440-021-00341-0 ;PMID: 34837648

Full text available

Citations Cited by
6
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir
Material Type:
Article 		Add to My Research

Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir

Daru, 2020-12, Vol.28 (2), p.625-634 [Peer Reviewed Journal]

Springer Nature Switzerland AG 2020 ;COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;ISSN: 2008-2231 ;ISSN: 1560-8115 ;EISSN: 2008-2231 ;DOI: 10.1007/s40199-020-00369-2 ;PMID: 32857301

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait